Assaad El-Hakim, MD, FRCS(C), Fellow in Urology, Cornell Institute of Robotic Surgery, Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY ...

Apa-RP: Multicenter phase 2 study of apalutamide (Apa) and androgen deprivation therapy (ADT) for the treatment of high-risk localized prostate cancer (HR LPC) following radical prostatectomy ...

Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a single-center study.

Bengaluru: In a significant global milestone in integrated surgical care, doctors at Fortis Hospital Bannerghatta Road, ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

With Men’s Health Week approaching, it is a good time to encourage open discussions about various health conditions, particularly prostate health. Driven by embarrassment, misconceptions, and a lack ...

Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies The ...

During the past eight years, the use of robotic-assisted laparoscopic prostatectomy (RALP) for prostate cancer has grown tremendously and at a pace almost unparalleled in modern surgery.

Urologic surgeon Jose M. Flores, MD is lead author of a new study investigating the risk of biochemical recurrence after radical prostatectomy when taking ED drugs. There have been conflicting studies ...